Furthermore, Cish-/- NK cells are somewhat resistant to the downregulation of IL-15R in the presence of IL-15, meaning that they maintain elevated and prolonged JAK/STAT signaling at sites of inflammation, including tumors, resulting in dramatic improvements in NK cell effector function and tumor immunity [81, 109, 110]. The gene discussed is IL15; the disease is neoplasm.